SEARCH
Search Details
Ide Tatsuya
Gastroenterology
Professor
Research activity information
■ Paper
■ 共同研究実績
■ 関心を持って取組んでいる活動
- Metabolic management after sustained virologic response in elderly patients with hepatitis C virus: A multicenter study.
Tomoya Sano; Keisuke Amano; Tatsuya Ide; Hiroshi Isoda; Yuichi Honma; Yasuyo Morita; Yoichi Yano; Hiroki Nakamura; Satoshi Itano; Ichiro Miyajima; Miki Shirachi; Reiichiro Kuwahara; Miki Ohno; Toshihiro Kawaguchi; Tsubasa Tsutsumi; Dan Nakano; Teruko Arinaga-Hino; Machiko Kawaguchi; Yuichiro Eguchi; Takuji Torimura; Hirokazu Takahashi; Masaru Harada; Takumi Kawaguchi
Hepatology research : the official journal of the Japan Society of Hepatology, Apr. 2024 - A combination of hepatic encephalopathy and body mass index was associated with the point of no return for improving liver functional reserve after sofosbuvir/velpatasvir treatment in patients with hepatitis C virus-related decompensated cirrhosis.
Tomoya Sano; Keisuke Amano; Tatsuya Ide; Keiji Yokoyama; Kazunori Noguchi; Hiroki Nakamura; Hiroshi Isoda; Miki Ohno; Miki Shirachi; Yasuyo Morita; Yoichi Yano; Shuji Sumie; Toshihiro Kawaguchi; Reiichiro Kuwahara; Teruko Arinaga-Hino; Hirokazu Takahashi; Satoshi Shakado; Fumihito Hirai; Takumi Kawaguchi
Hepatology research : the official journal of the Japan Society of Hepatology, Jan. 2023 - TAFRO Syndrome That Responded to Prednisolone-only Treatment: Evaluating Changes in IL-6.
Hiroyuki Suzuki; Tomoya Sano; Yasumasa Shimasaki; Maki Yamaguchi; Tatsuya Ide; Teruko Arinaga-Hino; Reiichiro Kuwahara; Keisuke Amano; Koichi Oshima; Koji Nagafuji; Hiroaki Ida; Hironori Koga; Takuji Torimura
Internal medicine (Tokyo, Japan), 01 Oct. 2022 - No increased risk of hepatocellular carcinoma after eradication of hepatitis C virus by direct-acting antivirals, compared with interferon-based therapy.
Masaaki Korenaga; Kazumoto Murata; Namiki Izumi; Nobuharu Tamaki; Osamu Yokosuka; Tetsuo Takehara; Naoya Sakamoto; Goki Suda; Shuhei Nishiguchi; Hirayuki Enomoto; Fusao Ikeda; Mikio Yanase; Hidenori Toyoda; Takuya Genda; Takeji Umemura; Hiroshi Yatsuhashi; Kazumi Yamasaki; Tatsuya Ide; Nobuo Toda; Tatsuo Kanda; Kazushige Nirei; Yoshiyuki Ueno; Hiroaki Haga; Yoichi Nishigaki; Kunio Nakane; Masao Omata; Hitoshi Mochizuki; Yoshihiko Aoki; Masatoshi Imamura; Tatsuya Kanto; Masashi Mizokami
Global health & medicine, 31 Aug. 2022 - Effect of Direct-Acting Antiviral Agents on Gastroesophageal Varices in Patients with Hepatitis C Virus-Related Cirrhosis.
Hiroshi Hisanaga; Hidetoshi Takedatsu; Keigo Emori; Hiroto Inoue; Yasuhumi Kunitake; Tomoyuki Nakane; Shuhei Fukunaga; Tatsuya Ide; Keiichi Mitsuyama; Takuji Torimura
Medicina (Kaunas, Lithuania), 10 Aug. 2022 - Growth differentiation factor 15 as a novel diagnostic and therapeutic marker for autoimmune hepatitis.
Teruko Arinaga-Hino; Tatsuya Ide; Jun Akiba; Hiroyuki Suzuki; Reiichiro Kuwahara; Keisuke Amano; Toshihiro Kawaguchi; Tomoya Sano; Eisuke Inoue; Hironori Koga; Keiichi Mitsuyama; Yasutoshi Koga; Takuji Torimura
Scientific reports, 24 May 2022 - Hepatitis C Virus Elimination Using Direct Acting Antivirals after the Radical Cure of Hepatocellular Carcinoma Suppresses the Recurrence of the Cancer.
Ryoko Kuromatsu; Tatsuya Ide; Shusuke Okamura; Yu Noda; Naoki Kamachi; Masahito Nakano; Tomotake Shirono; Shigeo Shimose; Hideki Iwamoto; Reiichiro Kuwahara; Teruko Arinaga-Hino; Takashi Niizeki; Yuki Zaizen; Hiroshi Takaki; Miki Shirachi; Hironori Koga; Takuji Torimura
Cancers, 04 May 2022 - Identification of microRNA-96-5p as a postoperative, prognostic microRNA predictor in nonviral hepatocellular carcinoma.
Takeshi Matsui; Susumu Hamada-Tsutsumi; Yutaka Naito; Masanori Nojima; Etsuko Iio; Akihiro Tamori; Shoji Kubo; Tatsuya Ide; Yasuteru Kondo; Yuichiro Eguchi; Atsumasa Komori; Yuji Morine; Mitsuo Shimada; Tohru Utsunomiya; Ken Shirabe; Koichi Kimura; Yoichi Hiasa; Natthaya Chuaypen; Pisit Tangkijvanich; Aya Naiki-Ito; Satoru Takahashi; Takahiro Ochiya; Yasuhito Tanaka
Hepatology research : the official journal of the Japan Society of Hepatology, Jan. 2022 - Case Report: A Rare Case of Benign Recurrent Intrahepatic Cholestasis-Type 1 With a Novel Heterozygous Pathogenic Variant of ATP8B1.
Hiroyuki Suzuki; Teruko Arinaga-Hino; Tomoya Sano; Yutaro Mihara; Hironori Kusano; Tatsuki Mizuochi; Takao Togawa; Shogo Ito; Tatsuya Ide; Reiichiro Kuwahara; Keisuke Amano; Toshihiro Kawaguchi; Hirohisa Yano; Masayoshi Kage; Hironori Koga; Takuji Torimura
Frontiers in medicine, 2022 - Switching from entecavir to tenofovir disoproxil fumarate for HBeAg-positive chronic hepatitis B patients: a phase 4, prospective study.
Fumitaka Suzuki; Yoshiyuki Suzuki; Yoshiyasu Karino; Yasuhito Tanaka; Masayuki Kurosaki; Hiroshi Yatsuhashi; Tomofumi Atarashi; Masanori Atsukawa; Tsunamasa Watanabe; Masaru Enomoto; Masatoshi Kudo; Naoto Maeda; Hiroshi Kohno; Kouji Joko; Kojiro Michitaka; Koichiro Miki; Kazuhiro Takahashi; Tatsuya Ide; Shigetoshi Fujiyama; Tomoko Kohno; Hiroshi Itoh; Sakiyo Tsukamoto; Yuko Suzuki; Yoshiaki Kawano; Wataru Sugiura; Hiromitsu Kumada
BMC gastroenterology, 20 Dec. 2021 - Enhanced liver fibrosis score as a predictive marker for hepatocellular carcinoma development after hepatitis C virus eradication.
Toshihiro Kawaguchi; Tatsuya Ide; Keisuke Amano; Teruko Arinaga-Hino; Reiichiro Kuwahara; Tomoya Sano; Shirachi Miki; Naofumi Ono; Takuji Torimura
Molecular and clinical oncology, Oct. 2021 - Tenofovir Alafenamide Rescues Renal Tubules in Patients with Chronic Hepatitis B.
Tomoya Sano; Takumi Kawaguchi; Tatsuya Ide; Keisuke Amano; Reiichiro Kuwahara; Teruko Arinaga-Hino; Takuji Torimura
Life (Basel, Switzerland), 23 Mar. 2021 - Prednisolone-responsive primary sclerosing cholangitis with autoimmune hemolytic anemia: a case report and review of the literature.
Toshihiro Kawaguchi; Teruko Arinaga-Hino; Satoshi Morishige; Shinji Mizuochi; Mitsuhiko Abe; Kazuya Kunitake; Tomoya Sano; Keisuke Amano; Reiichiro Kuwahara; Tatsuya Ide; Koji Nagafuji; Takuji Torimura
Clinical journal of gastroenterology, Feb. 2021 - Eradication of hepatitis C virus with direct-acting antivirals improves glycemic control in diabetes: A multicenter study.
Hirokazu Takahashi; Takashi Nakahara; Tomomi Kogiso; Kento Imajo; Takaomi Kessoku; Takumi Kawaguchi; Tatsuya Ide; Miwa Kawanaka; Hideyuki Hyogo; Hideki Fujii; Masafumi Ono; Yoshihiro Kamada; Yoshio Sumida; Keizo Anzai; Masahito Shimizu; Takuji Torimura; Atsushi Nakajima; Katsutoshi Tokushige; Kazuaki Chayama; Yuichiro Eguchi
JGH open : an open access journal of gastroenterology and hepatology, Feb. 2021 - Short-term efficacy after switching from adefovir dipivoxil and tenofovir disoproxil fumarate therapy to tenofovir alaferamide for chronic hepatitis B.
Tomoya Sano; Keisuke Amano; Tatsuya Ide; Toshihiro Kawaguchi; Reiichiro Kuwahara; Teruko Arinaga-Hino; Hironori Koga; Ryoko Kuromatsu; Takuji Torimura
Biomedical reports, Jan. 2021 - Real-World Effectiveness From the Asia Pacific Rim Liver Consortium for HBV Risk Score for the Prediction of Hepatocellular Carcinoma in Chronic Hepatitis B Patients Treated With Oral Antiviral Therapy.
Hwai-I Yang; Ming-Lun Yeh; Grace L Wong; Cheng-Yuan Peng; Chien-Hung Chen; Huy N Trinh; Ka-Shing Cheung; Qing Xie; Tung-Hung Su; Ritsuzo Kozuka; Dong-Hyun Lee; Eiichi Ogawa; Changqing Zhao; Hui-Bin Ning; Rui Huang; Jiayi Li; Jian Q Zhang; Tatsuya Ide; Huichun Xing; Shinji Iwane; Hirokazu Takahashi; Christopher Wong; Clifford Wong; Chia-Hsin Lin; Joseph Hoang; An Le; Linda Henry; Hidenori Toyoda; Yoshiyuki Ueno; Edward J Gane; Yuichiro Eguchi; Masayuki Kurosaki; Chao Wu; Chenghai Liu; Jia Shang; Norihiro Furusyo; Masaru Enomoto; Jia-Horng Kao; Man-Fung Yuen; Ming-Lung Yu; Mindie H Nguyen
The Journal of infectious diseases, 14 Jan. 2020 - Histological changes in patients who developed hepatocellular carcinoma after hepatitis C virus eradication by interferon-based therapy.
Toshihiro Kawaguchi; Tatsuya Ide; Reiichiro Kondo; Yoriko Nomura; Teruko Arinaga-Hino; Reiichiro Kuwahara; Keisuke Amano; Tomoya Sano; Jun Akiba; Koichi Ohshima; Hirohisa Yano; Takuji Torimura
Experimental and therapeutic medicine, Nov. 2019 - Sustained virologic response to direct-acting antiviral therapy in patients with chronic hepatitis C and hepatocellular carcinoma: A systematic review and meta-analysis.
Fanpu Ji; Yee Hui Yeo; Mike Tzuhen Wei; Eiichi Ogawa; Masaru Enomoto; Dong Hyun Lee; Etsuko Iio; John Lubel; Wenjun Wang; Bin Wei; Tatsuya Ide; Carmen Monica Preda; Fabio Conti; Tatsuya Minami; Rob Bielen; Hitomi Sezaki; Michele Barone; Philippe Kolly; Po-Sung Chu; Victor Virlogeux; Dennis Eurich; Linda Henry; Michelle B Bass; Takanori Kanai; Shuangsuo Dang; Zongfang Li; Jean-François Dufour; Fabien Zoulim; Pietro Andreone; Ramsey C Cheung; Yasuhito Tanaka; Norihiro Furusyo; Hidenori Toyoda; Akihiro Tamori; Mindie H Nguyen
Journal of hepatology, Sep. 2019 - Immune-mediated Drug-induced Liver Injury Caused by Laninamivir Octanoate Hydrate.
Toshihiro Kawaguchi; Teruko Arinaga-Hino; Motoki Shimizu; Ken Tanikawa; Takahiko Tokushige; Shingo Hirai; Hiroaki Nagamatsu; Hideo Tateishi; Akio Takata; Tatsuya Ide; Takuji Torimura
Internal medicine (Tokyo, Japan), 01 Sep. 2019 - Predictors of hepatocellular carcinoma recurrence associated with the use of direct-acting antiviral agent therapy for hepatitis C virus after curative treatment: A prospective multicenter cohort study.
Masahito Nakano; Hironori Koga; Tatsuya Ide; Ryoko Kuromatsu; Satoru Hashimoto; Hiroshi Yatsuhashi; Masataka Seike; Nobito Higuchi; Makoto Nakamuta; Satoshi Shakado; Shotaro Sakisaka; Satoshi Miuma; Kazuhiko Nakao; Yoko Yoshimaru; Yutaka Sasaki; Satoshi Oeda; Yuichiro Eguchi; Yuichi Honma; Masaru Harada; Kenji Nagata; Seiichi Mawatari; Akio Ido; Tatsuji Maeshiro; Shuichi Matsumoto; Yuko Takami; Tetsuo Sohda; Takuji Torimura
Cancer medicine, May 2019 - Direct-acting antiviral agents do not increase the incidence of hepatocellular carcinoma development: a prospective, multicenter study.
Tatsuya Ide; Hironori Koga; Masahito Nakano; Satoru Hashimoto; Hiroshi Yatsuhashi; Nobito Higuchi; Makoto Nakamuta; Satoshi Oeda; Yuichiro Eguchi; Satoshi Shakado; Shotaro Sakisaka; Yoko Yoshimaru; Yutaka Sasaki; Yuichi Honma; Masaru Harada; Masataka Seike; Tatsuji Maeshiro; Satoshi Miuma; Kazuhiko Nakao; Seiichi Mawatari; Akio Ido; Kenji Nagata; Shuichi Matsumoto; Yuko Takami; Tetsuo Sohda; Tatsuyuki Kakuma; Takuji Torimura
Hepatology international, May 2019 - Marked accumulation of fluorodeoxyglucose and inflammatory cells expressing glucose transporter-3 in immunoglobulin G4-related autoimmune hepatitis.
Toshihiro Araki; Teruko Arinaga-Hino; Hironori Koga; Jun Akiba; Tatsuya Ide; Yoshinobu Okabe; Reiichiro Kuwahara; Keisuke Amano; Makiko Yasumoto; Toshihiro Kawaguchi; Tomoya Sano; Reiichiro Kondou; Seiji Kurata; Keiichi Mitsuyama; Takuji Torimura
Hepatology research : the official journal of the Japan Society of Hepatology, Oct. 2018 - Sofosbuvir-velpatasvir plus ribavirin in Japanese patients with genotype 1 or 2 hepatitis C who failed direct-acting antivirals.
Namiki Izumi; Tetsuo Takehara; Kazuaki Chayama; Hiroshi Yatsuhashi; Koichi Takaguchi; Tatsuya Ide; Masayuki Kurosaki; Yoshiyuki Ueno; Hidenori Toyoda; Satoru Kakizaki; Yasuhito Tanaka; Yoshiiku Kawakami; Hirayuki Enomoto; Fusao Ikeda; Deyuan Jiang; Shampa De-Oertel; Brian L McNabb; Gregory Camus; Luisa M Stamm; Diana M Brainard; John G McHutchison; Satoshi Mochida; Masashi Mizokami
Hepatology international, Jul. 2018 - Risk of malignancies in autoimmune hepatitis type 1 patients with a long-term follow-up in Japan.
Teruko Arinaga-Hino; Tatsuya Ide; Ichiro Miyajima; Kei Ogata; Reiichiro Kuwahara; Keisuke Amano; Toshihiro Kawaguchi; Toru Nakamura; Takumi Kawaguchi; Hironori Koga; Koji Yonemoto; Takuji Torimura
Hepatology research : the official journal of the Japan Society of Hepatology, Feb. 2018 - Rapidly growing hepatocellular carcinoma after direct-acting antiviral treatment of chronic hepatitis C.
Toshihiro Kawaguchi; Tatsuya Ide; Hironori Koga; Reiichiro Kondo; Ichiro Miyajima; Teruko Arinaga-Hino; Reiichiro Kuwahara; Keisuke Amano; Takashi Niizeki; Masahito Nakano; Ryoko Kuromatsu; Takuji Torimura
Clinical journal of gastroenterology, Feb. 2018 - Genome-Wide Association Study Identifies TLL1 Variant Associated With Development of Hepatocellular Carcinoma After Eradication of Hepatitis C Virus Infection.
Kentaro Matsuura; Hiromi Sawai; Kazuho Ikeo; Shintaro Ogawa; Etsuko Iio; Masanori Isogawa; Noritomo Shimada; Atsumasa Komori; Hidenori Toyoda; Takashi Kumada; Tadashi Namisaki; Hitoshi Yoshiji; Naoya Sakamoto; Mina Nakagawa; Yasuhiro Asahina; Masayuki Kurosaki; Namiki Izumi; Nobuyuki Enomoto; Atsunori Kusakabe; Eiji Kajiwara; Yoshito Itoh; Tatsuya Ide; Akihiro Tamori; Misako Matsubara; Norifumi Kawada; Ken Shirabe; Eiichi Tomita; Masao Honda; Shuichi Kaneko; Sohji Nishina; Atsushi Suetsugu; Yoichi Hiasa; Hisayoshi Watanabe; Takuya Genda; Isao Sakaida; Shuhei Nishiguchi; Koichi Takaguchi; Eiji Tanaka; Junichi Sugihara; Mitsuo Shimada; Yasuteru Kondo; Yosuke Kawai; Kaname Kojima; Masao Nagasaki; Katsushi Tokunaga; Yasuhito Tanaka
Gastroenterology, May 2017 - Clinical Significance of Two Real-Time PCR Assays for Chronic Hepatitis C Patients Receiving Protease Inhibitor-Based Therapy.
Takako Inoue; Su Su Hmwe; Noritomo Shimada; Keizo Kato; Tatsuya Ide; Takuji Torimura; Takashi Kumada; Hidenori Toyoda; Akihito Tsubota; Koichi Takaguchi; Takaji Wakita; Yasuhito Tanaka
PloS one, Jan. 2017 - An analysis of drug-induced liver injury, which showed histological findings similar to autoimmune hepatitis.
Akiko Hisamochi; Masayoshi Kage; Tatsuya Ide; Teruko Arinaga-Hino; Keisuke Amano; Reiichiro Kuwahara; Kei Ogata; Ichiro Miyajima; Ryukichi Kumashiro; Michio Sata; Takuji Torimura
Journal of gastroenterology, Jun. 2016 - Understanding of HLA-conferred susceptibility to chronic hepatitis B infection requires HLA genotyping-based association analysis.
Nao Nishida; Jun Ohashi; Seik-Soon Khor; Masaya Sugiyama; Takayo Tsuchiura; Hiromi Sawai; Keisuke Hino; Masao Honda; Shuichi Kaneko; Hiroshi Yatsuhashi; Osamu Yokosuka; Kazuhiko Koike; Masayuki Kurosaki; Namiki Izumi; Masaaki Korenaga; Jong-Hon Kang; Eiji Tanaka; Akinobu Taketomi; Yuichiro Eguchi; Naoya Sakamoto; Kazuhide Yamamoto; Akihiro Tamori; Isao Sakaida; Shuhei Hige; Yoshito Itoh; Satoshi Mochida; Eiji Mita; Yasuhiro Takikawa; Tatsuya Ide; Yoichi Hiasa; Hiroto Kojima; Ken Yamamoto; Minoru Nakamura; Hiroh Saji; Takehiko Sasazuki; Tatsuya Kanto; Katsushi Tokunaga; Masashi Mizokami
Scientific reports, 19 Apr. 2016 - A novel glycobiomarker, Wisteria floribunda agglutinin macrophage colony-stimulating factor receptor, for predicting carcinogenesis of liver cirrhosis.
Etsuko Iio; Makoto Ocho; Akira Togayachi; Masanori Nojima; Atsushi Kuno; Yuzuru Ikehara; Izumi Hasegawa; Hiroshi Yatsuhashi; Kazumi Yamasaki; Noritomo Shimada; Tatsuya Ide; Noboru Shinkai; Shunske Nojiri; Kei Fujiwara; Takashi Joh; Masashi Mizokami; Hisashi Narimatsu; Yasuhito Tanaka
International journal of cancer, 15 Mar. 2016 - Genome-Wide Association Study Identifies ZNF354C Variants Associated with Depression from Interferon-Based Therapy for Chronic Hepatitis C.
Kayoko Matsunami; Nao Nishida; Naoko Kaneko; Kazuho Ikeo; Licht Toyo-Oka; Hiroshi Takeuchi; Kentaro Matsuura; Akihiro Tamori; Hideyuki Nomura; Hitoshi Yoshiji; Masatoshi Imamura; Naohiko Masaki; Tatsuro Hayakawa; Tatsuya Ide; Noritomo Shimada; Fusao Ikeda; Keisuke Hino; Shuhei Nishiguchi; Chiaki Okuse; Shunsuke Nojiri; Kazunobu Sawamoto; Katsushi Tokunaga; Takashi Joh; Yasuhito Tanaka
PloS one, 2016 - Evaluation of Resistance-Associated Substitutions in NS5A Using Direct Sequence and Cycleave Method and Treatment Outcome with Daclatasvir and Asunaprevir for Chronic Hepatitis C Genotype 1.
Tatsuya Ide; Yuichiro Eguchi; Masaru Harada; Kunihide Ishii; Masaru Morita; Yasuyo Morita; Gen Sugiyama; Hirofumi Fukushima; Yoichi Yano; Kazunori Noguchi; Hiroki Nakamura; Junjiro Hisatomi; Hiroto Kumemura; Miki Shirachi; Shinji Iwane; Michiaki Okada; Yuichi Honma; Teruko Arinaga-Hino; Ichiro Miyajima; Kei Ogata; Reiichiro Kuwahara; Keisuke Amano; Toshihiro Kawaguchi; Ryoko Kuromatsu; Takuji Torimura
PloS one, Sep. 2016 - Ledipasvir and sofosbuvir fixed-dose combination with and without ribavirin for 12 weeks in treatment-naive and previously treated Japanese patients with genotype 1 hepatitis C: an open-label, randomised, phase 3 trial.
Masashi Mizokami; Osamu Yokosuka; Tetsuo Takehara; Naoya Sakamoto; Masaaki Korenaga; Hitoshi Mochizuki; Kunio Nakane; Hirayuki Enomoto; Fusao Ikeda; Mikio Yanase; Hidenori Toyoda; Takuya Genda; Takeji Umemura; Hiroshi Yatsuhashi; Tatsuya Ide; Nobuo Toda; Kazushige Nirei; Yoshiyuki Ueno; Yoichi Nishigaki; Juan Betular; Bing Gao; Akinobu Ishizaki; Masa Omote; Hongmei Mo; Kim Garrison; Phillip S Pang; Steven J Knox; William T Symonds; John G McHutchison; Namiki Izumi; Masao Omata
The Lancet. Infectious diseases, Jun. 2015 - Genome-wide association study identifies a PSMD3 variant associated with neutropenia in interferon-based therapy for chronic hepatitis C
Iio E, Matsuura K, Nishida N, Maekawa S, Enomoto N, Nakagawa M, Sakamoto N, Yatsuhashi H, Kurosaki M, Izumi N, Hiasa Y, Masaki N, Ide T, Hino K, Tamori A, Honda M, Kaneko S, Mochida S, Nomura H, Nishiguchi S, Okuse C, Itoh Y, Yoshiji H, Sakaida I, Yamamoto K, Watanabe H, Hige S, Matsumoto A, Tanaka E, Tokunaga K, Tanaka Y
Hum Genet, Mar. 2015 - A 48-week telaprevir-based triple combination therapy improves sustained virological response rate in previous non-responders to peginterferon and ribavirin with genotype 1b chronic hepatitis C: A multicenter study
Shimada N, Tsubota A, Atsukawa M, Abe H, Ide T, Takaguchi K, Chuganji Y, Toyoda H, Yoshizawa K, Ika M, Sato Y, Kato K, Kumada T, Sakamoto C, Aizawa Y, Sata M
Hepatol Res, Dec. 2014 - Time trends of clinical characteristics in hepatocellular carcinoma patients with chronic hepatitis B virus infection: A field survey between 2000 and 2012.
Keisuke Amano; Takumi Kawaguchi; Ryoko Kuromatsu; Atsushi Kawaguchi; Ichiro Miyajima; Tatsuya Ide; Tatsuyuki Kakuma; Michio Sata
Molecular and clinical oncology, Nov. 2014 - Sofosbuvir plus ribavirin in Japanese patients with chronic genotype 2 HCV infection: an open-label, phase 3 trial
Omata M, Nishiguchi S, Ueno Y, Mochizuki H, Izumi N, Ikeda F, Toyoda H, Yokosuka O, Nirei K, Genda T, Umemura T, Takehara T, Sakamoto N, Nishigaki Y, Nakane K, Toda N, Ide T, Yanase M, Hino K, Gao B, Garrison KL, Dvory-Sobol H, Ishizaki A, Omote M, Brainard D, Knox S, Symonds WT, McHutchison JG, Yatsuhashi H, Mizokami M
J Viral Hepat, Nov. 2014 - Characteristics and outcomes of HCV genotype-1-infected patients treated with peginterferon and ribavirin combination therapy with discordant HCV responses 4 and 12 weeks after starting therapy
Toyoda H, Kumada T, Shimada N, Takaguchi K, Ide T, Sata M, Ginba H, Matsuyama K, Izumi N
Intervirology, Jun. 2014 - Predictors of response to 24-week telaprevir-based triple therapy for treatment-naïve genotype 1b chronic hepatitis C patients.
Hiroshi Abe; Akihito Tsubota; Noritomo Shimada; Masanori Atsukawa; Keizo Kato; Koichi Takaguchi; Toru Asano; Yoshimichi Chuganji; Choitsu Sakamoto; Hidenori Toyoda; Takashi Kumada; Tatsuya Ide; Michio Sata; Yoshio Aizawa
Gastroenterology research and practice, 2014 - New susceptibility and resistance HLA-DP alleles to HBV-related diseases identified by a trans-ethnic association study in Asia.
Nao Nishida; Hiromi Sawai; Koichi Kashiwase; Mutsuhiko Minami; Masaya Sugiyama; Wai-Kay Seto; Man-Fung Yuen; Nawarat Posuwan; Yong Poovorawan; Sang Hoon Ahn; Kwang-Hyub Han; Kentaro Matsuura; Yasuhito Tanaka; Masayuki Kurosaki; Yasuhiro Asahina; Namiki Izumi; Jong-Hon Kang; Shuhei Hige; Tatsuya Ide; Kazuhide Yamamoto; Isao Sakaida; Yoshikazu Murawaki; Yoshito Itoh; Akihiro Tamori; Etsuro Orito; Yoichi Hiasa; Masao Honda; Shuichi Kaneko; Eiji Mita; Kazuyuki Suzuki; Keisuke Hino; Eiji Tanaka; Satoshi Mochida; Masaaki Watanabe; Yuichiro Eguchi; Naohiko Masaki; Kazumoto Murata; Masaaki Korenaga; Yoriko Mawatari; Jun Ohashi; Minae Kawashima; Katsushi Tokunaga; Masashi Mizokami
PloS one, Feb. 2014 - Clinical characteristics of patients who developed hepatocellular carcinoma after hepatitis C virus eradication with interferon therapy: current status in Japan
Sato A, Sata M, Ikeda K, Kumada T, Izumi N, Asahina Y, Osaki Y, Chayama K, Kaneko S, Sakai A, Onji M, Hiasa Y, Omura T, Ozeki I, Yokosuka O, Shiina S, Itsubo M, Nishiguchi S, Hirano K, Ide T, Sakisaka S, Yamasaki T, Hidaka I, Tanaka M, Kim SR, Ichida T
Intern Med, Dec. 2013 - Drug-induced liver injury associated with Agaricus blazei Murill which is very similar to autoimmune hepatitis.
Akiko Hisamochi; Masayoshi Kage; Teruko Arinaga; Tatsuya Ide; Ichiro Miyajima; Kei Ogata; Reiichiro Kuwahara; Yuriko Koga; Ryukichi Kumashiro; Michio Sata
Clinical journal of gastroenterology, Apr. 2013 - Baseline factors and early viral response (week 4) to antiviral therapy with peginterferon and ribavirin for predicting sustained virologic response in patients infected with hepatitis C virus genotype 1: A multicenter study
Toyoda H, Kumada T, Shimada N, Takaguchi K, Ide T, Sata M, Ginba H, Matsuyama K, Izumi N
J Med Virol, Jan. 2013 - Long-term outcome of splenectomy in advanced cirrhotic patients with hepatocellular carcinoma and thrombocytopenia.
Toshiro Ogata; Koji Okuda; Toshihiro Sato; Yusuke Hirakawa; Masafumi Yasunaga; Hiroyuki Horiuchi; Yoriko Nomura; Masayoshi Kage; Tatsuya Ide; Ryoko Kuromatsu; Hisafumi Kinoshita; Hiroyuki Tanaka
The Kurume medical journal, Apr. 2013 - Clinical features of cirrhosis in Japanese patients with type I autoimmune hepatitis
Abe K, Katsushima F, Kanno Y, Takahashi A, Yokokawa J, Ohira H, Arinaga T, Ide T, Nishimura J, Inoue M, Seike M, Imazeki F, Yokosuka O, Sata M
Intern Med, Dec. 2012 - Effect of branched-chain amino acid-enriched nutritional supplementation on interferon therapy in Japanese patients with chronic hepatitis C virus infection: a retrospective study.
Yumiko Nagao; Takumi Kawaguchi; Tatsuya Ide; Michio Sata
Virology journal, 22 Nov. 2012 - Significance of a reduction in HCV RNA levels at 4 and 12 weeks in patients infected with HCV genotype 1b for the prediction of the outcome of combination therapy with peginterferon and ribavirin
Toyoda H, Kumada T, Shimada N, Takaguchi K, Ide T, Sata M, Ginba H, Matsuyama K, Izumi N
BMC Infect Dis, Nov. 2012 - Risk factors for hepatocellular carcinoma in Japanese patients with autoimmune hepatitis type 1.
Teruko Hino-Arinaga; Tatsuya Ide; Ryoko Kuromatsu; Ichiro Miyajima; Kei Ogata; Reiichiro Kuwahara; Akiko Hisamochi; Takuji Torimura; Michio Sata
Journal of gastroenterology, May 2012 - The importance of a prior psychiatric examination in pegylated interferon and ribavirin combination treatment for chronic hepatitis C.
Koichiro Kuhara; Tatsuya Ide; Naohisa Uchimura; Ryukichi Kumashiro; Teruko Arinaga; Ichiro Miyajima; Shiro Murashima; Kei Ogata; Reiichiro Kuwahara; Keisuke Amano; Yukari Fujimoto; Kenji Sakai; Kunihide Ishii; Yasuyo Morita; Miki Shirachi; Michio Sata
The Kurume medical journal, 2012 - [Virus removal and eradication by double filtration plasmapheresis (DFPP)].
Tatsuya Ide
Nihon rinsho. Japanese journal of clinical medicine, May 2011 - Trajectories of ant-islet autoantibodies before development of type 1 diabetes in interferon-treated hepatitis C patients. Case reports and a literature review
Nakamura K, Kawasaki E, Abiru N, Jo O, Fukushima K, Satoh T, Kuriya G, Kobayashi M, Kuwahara H, Yamasaki H, Ide T, Eguchi K
Endocr J, Nov. 2010 - Efficacy and safety of double filtration plasmapheresis in combination with interferon therapy for chronic hepatitis C
Kaneko S, Sata M, Ide T, Yamashita T, Hige S, Tomita E, Mochida S, Yamashita Y, Inui Y, Kim SR, Komada N, Mikami T, Satoh S, Morita S, Takaguchi K, Hirashima N, Nishio Y, Watanabe D, Kioka K, Fujiwara K
Hepatol Res, Nov. 2010 - Adipocytokine involvement in hepatocellular carcinoma after sustained response to interferon for chronic hepatitis C.
Nobuyoshi Fukushima; Ryoko Kuromatsu; Teruko Arinaga-Hino; Eiji Ando; Akio Takata; Shuji Sumie; Masahito Nakano; Takumi Kawaguchi; Tatsuya Ide; Takuji Torimura; Michio Sata
Hepatology research : the official journal of the Japan Society of Hepatology, Sep. 2010 - Peginterferon-alpha-2b plus ribavirin therapy in patients with chronic hepatitis C as assessed by a multi-institutional questionnaire in Japan.
Tatsuya Ide; Michio Sata; Shotaro Sakisaka; Makoto Nakamuta; Shigetoshi Fujiyama; Toshihiko Mizuta; Kenji Tahara; Kunio Fujisaki; Yasuji Komorizono; Hiroshi Watanabe; Yasuyo Morita; Hirohito Tsubouchi
Hepatology research : the official journal of the Japan Society of Hepatology, Jun. 2010 - Evaluation of long-term entecavir treatment in stable chronic hepatitis B patients switched from lamivudine therapy
Ide T, Sata M, Chayama K, Shindo M, Toyota J, Mochida S, Tomita E, Kumada H, Yamada G, Yatsuhashi H, Hayashi N, Ishikawa H, Seriu T, Omata M
Hepatol Int, 2010 - Phase I clinical study of a peptide vaccination for hepatitis C virus-infected patients with different human leukocyte antigen-class I-A alleles.
Shigeru Yutani; Nobukazu Komatsu; Shigeki Shichijo; Kazumi Yoshida; Hiroko Takedatsu; Minoru Itou; Ryoko Kuromatu; Tatsuya Ide; Masatoshi Tanaka; Michio Sata; Akira Yamada; Kyogo Itoh
Cancer science, Oct. 2009 - Knowledge of Vibrio vulnificus infection among Japanese patients with liver diseases: a prospective multicenter study.
Yumiko Nagao; Hisako Matsuoka; Masataka Seike; Kazumi Yamasaki; Junji Kato; Takeyuki Nakajima; Yutaka Miyazaki; Tomoyoshi Ohno; Sadataka Inuzuka; Hiromasa Ohira; Osamu Yokosuka; Hiroshi Yatsuhashi; Tetsu Mori; Koichi Honda; Takumi Kawaguchi; Tatsuya Ide; Michio Sata
Medical science monitor : international medical journal of experimental and clinical research, Oct. 2009 - Thrombocytopenia, an important interfering factor of antiviral therapy and hepatocellular carcinoma treatment for chronic liver diseases.
Takumi Kawaguchi; Ryoko Kuromatsu; Tatsuya Ide; Eitaro Taniguchi; Minoru Itou; Masahiro Sakata; Mitsuhiko Abe; Shuji Sumie; Michio Sata
The Kurume medical journal, 2009 - A randomized study of extended treatment with peginterferon alpha-2b plus ribavirin based on time to HCV RNA negative-status in patients with genotype 1b chronic hepatitis C.
Tatsuya Ide; Teruko Hino; Kei Ogata; Ichiro Miyajima; Reiichiro Kuwahara; Koichiro Kuhara; Michio Sata
The American journal of gastroenterology, Jan. 2009 - Predictive factors associated with the progression to hepatic failure caused by lamivudine-resistant HBV.
Reiichiro Kuwahara; Ryukichi Kumashiro; Tatsuya Ide; Yuriko Koga; Teruko Hino; Akiko Hisamochi; Kazuo Tanaka; Kei Ogata; Hiroyuki Koga; Yukari Takao; Michio Sata
Digestive diseases and sciences, Nov. 2008 - Branched-chain amino acid-enriched supplementation improves insulin resistance in patients with chronic liver disease.
Takumi Kawaguchi; Yumiko Nagao; Hisako Matsuoka; Tatsuya Ide; Michio Sata
International journal of molecular medicine, Jul. 2008 - HBV and HCV infection in Japanese dental care workers.
Yumiko Nagao; Hisako Matsuoka; Takumi Kawaguchi; Tatsuya Ide; Michio Sata
International journal of molecular medicine, Jun. 2008 - HCV or HBV Infection Self-disclosure to Dentists
NAGAO Yumiko; KAWAGUCHI Takumi; IDE Tatsuya; SATA Michio
Kansenshogaku Zasshi, May 2008 - A mutational shift from domain III to II in the internal ribosome entry site of hepatitis C virus after interferon-ribavirin therapy.
Kei Ogata; Takahito Kashiwagi; Jun Iwahashi; Koyu Hara; Haruhito Honda; Tatsuya Ide; Ryukichi Kumashiro; Michinori Kohara; Michio Sata; Hiroshi Watanabe; Nobuyuki Hamada
Archives of virology, 2008 - I. B型肝炎治療の新戦略 3. 核酸アナログ製剤によるB型慢性肝炎の治療
井出達也、佐田通夫
化学療法の領域, Jan. 2008 - [A periappendiceal abscess during combination interferon and ribavirin treatment for chronic hepatitis C].
Teruko Hino; Tatsuya Ide; Takeshi Toubaru; Hiroko Korekoda; Hiroshi Kawano; Akiko Hisamochi; Koichiro Kuhara; Osamu Tsuruta; Ryukichi Kumashiro; Michio Sata
Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology, Nov. 2007 - A periappendiceal abscess during combination interferon and ribavirin treatment for chronic hepatitis C
HINO Teruko; IDE Tatsuya; TOUBARU Takeshi; KOREKODA Hiroko; KAWANO Hiroshi; HISAMOCHI Akiko; KUHARA Koichiro; TSURUTA Osamu; KUMASHIRO Ryukichi; SATA Michio
Nippon Shokakibyo Gakkai Zasshi, Nov. 2007 - Phase I clinical study of a personalized peptide vaccination for patients infected with hepatitis C virus (HCV) 1b who failed to respond to interferon-based therapy.
Shigeru Yutani; Akira Yamada; Kazumi Yoshida; Yukari Takao; Mayumi Tamura; Nobukazu Komatsu; Tatsuya Ide; Masatoshi Tanaka; Michio Sata; Kyogo Itoh
Vaccine, 16 Oct. 2007 - Serum levels of IgG to the peptide of HCV1b core at positions 35-44 correlated with persistent infection, while levels of IgG to the peptide of NS5A at positions 2132-2140 correlated with better prognosis in HCV-infected patients.
Yukari Takao; Akira Yamada; Shigeru Yutani; Takeharu Ono; Yumiko Nagao; Eiji Ando; Tatsuya Ide; Kyogo Itoh; Michio Sata
Medical microbiology and immunology, Sep. 2007 - A new epitope peptide derived from hepatitis C virus 1b possessing the capacity to induce cytotoxic T-lymphocytes in HCV1b-infected patients with HLA-A11, -A31, and -A33.
Satoko Matsueda; Akira Yamada; Yukari Takao; Mayumi Tamura; Nobukazu Komatsu; Shigeru Yutani; Tatsuya Ide; Michio Sata; Kyogo Itoh
Cancer immunology, immunotherapy : CII, Sep. 2007 - Lamivudine treatment-related morphological changes of esophageal varices in patients with liver cirrhosis.
Hiroyuki Koga; Tatsuya Ide; Kazuhiko Oho; Reiichiro Kuwahara; Teruko Hino; Kei Ogata; Akiko Hisamochi; Kazuo Tanaka; Ryukichi Kumashiro; Atsushi Toyonaga; Michio Sata
Hepatology research : the official journal of the Japan Society of Hepatology, Jul. 2007 - Clearance of HCV improves insulin resistance, beta-cell function, and hepatic expression of insulin receptor substrate 1 and 2
Kawaguchi T, Ide T, Taniguchi E, Hirano E, Itou M, Sumie S, Nagao Y, Yanagimoto C, Hanada S, Koga H, Sata M.
American Journal of Gastroenterology, May 2007 - Successful treatment with corticosteroid and lamivudine for autoimmune hepatitis in a patient with asymptomatic HBV infection.
Reiichiro Kuwahara; Hiroki Saitsu; Mitsuhiko Abe; Akio Takata; Kazuo Tanaka; Teruko Hino; Tatsuya Ide; Ryoko Kuromatsu; Ken Tanikawa; Masayoshi Kage; Ryukichi Kumashiro; Michio Sata
Digestive diseases and sciences, Apr. 2007 - Identification of new immunogenic peptides in conserved regions of hepatitis C virus (HCV) 1b with the potentiality to generate cytotoxic T lymphocytes in HCV1b(+) HLA-A24(+) patients.
Yukari Takao; Akira Yamada; Shigeru Yutani; Hiroko Takedatsu; Takeharu Ono; Kojyu Etoh; Yi Wang; Susumu Suzuki; Tatsuya Ide; Kunitada Shimotohno; Michio Sata; Kyogo Itoh
Hepatology research : the official journal of the Japan Society of Hepatology, Mar. 2007 - Impaired filterability of erythrocytes from patients with chronic hepatitis C and effects of eicosapentaenoic acid on the filterability.
Ritsuko Seki; Takashi Okamura; Tatsuya Ide; Masayoshi Kage; Michio Sata; Nobuhiro Uyesaka; Toru Maruyama
The journal of physiological sciences : JPS, Feb. 2007 - Granulocytapheresis (GCAP) for severe alcoholic hepatitis-A preliminary report.
Ryukichi Kumashiro; Yuriko Koga; Reiichirou Kuwahara; Tatsuya Ide; Teruko Hino; Kazuo Tanaka; Akiko Hisamochi; Kei Ogata; Yukari Takao; Hiroyuki Koga; Hidemi Nishida; Seiya Okuda; Teruo Sakamoto; Michio Sata
Hepatology research : the official journal of the Japan Society of Hepatology, Nov. 2006 - Clinical Evaluation of Double Filtration Plasmapheresis and Interferon/Ribavirin Combination Therapy for Patients with Chronic Hepatitis C
Ide,Tatsuya; Nishida,Hidemi; Yano,Jyunko; Tanaka,Hideharu; Okuda,Seiya; Sata,Michio
日本アフェレシス学会雑誌, 31 Oct. 2006 - Antibody to hepatitis B core antigen is associated with the development of hepatocellular carcinoma in hepatitis C virus-infected persons: a 12-year prospective study.
Kazuo Tanaka; Yumiko Nagao; Tatsuya Ide; Ryukichi Kumashiro; Michio Sata
International journal of molecular medicine, May 2006 - A decrease in AFP level related to administration of interferon in patients with chronic hepatitis C and a high level of AFP.
Shiro Murashima; Masatoshi Tanaka; Makoto Haramaki; Shigeru Yutani; Yutaka Nakashima; Kazunori Harada; Tatsuya Ide; Ryukichi Kumashiro; Michio Sata
Digestive diseases and sciences, Apr. 2006 - New epitope peptides derived from hepatitis C virus (HCV) 2a which have the capacity to induce cytotoxic T lymphocytes in HLA-A2+ HCV-infected patients.
Yi Wang; Yukari Takao; Mamoru Harada; Shigeru Yutani; Tatsuya Ide; Michio Sata; Kyogo Itoh; Akira Yamada
Microbiology and immunology, 2006 - Clinical features of hepatocellular carcinoma that occur after sustained virological response to interferon for chronic hepatitis C
Ikeda M, Fujiyama S, Tanaka M, Sata M, Ide T, Yatsuhashi H, Watanabe H
J Gastroenterol Hepatol, 2006 - Timing of interferon therapy and sources of infection in patients with acute hepatitis C.
Kei Ogata; Tatsuya Ide; Ryukichi Kumashiro; Hiromitsu Kumada; Hiroshi Yotsuyanagi; Kiwamu Okita; Yoshihiro Akahane; Shuichi Kaneko; Hirohito Tsubouchi; Eiji Tanaka; Hisataka Moriwaki; Shuhei Nishiguchi; Shinichi Kakumu; Masashi Mizokami; Shiro Iino; Michio Sata
Hepatology research : the official journal of the Japan Society of Hepatology, Jan. 2006 - Identification of hepatitis C virus 1b-derived peptides recognized by both cellular and humoral immune systems in HCV1b(+) HLA-A24(+) patients.
Mayumi Tamura; Akira Yamada; Yukari Takao; Satoko Matsueda; Nobukazu Komatsu; Shigeru Yutani; Tatsuya Ide; Michio Sata; Kyogo Itoh
Hepatology research : the official journal of the Japan Society of Hepatology, Aug. 2005 - Causal relationship between hepatitis C virus core and the development of type 2 diabetes mellitus in a hepatitis C virus hyperendemic area: a pilot study.
Takumi Kawaguchi; Yumiko Nagao; Kazuo Tanaka; Tatsuya Ide; Masaru Harada; Ryukichi Kumashiro; Michio Sata
International journal of molecular medicine, Jul. 2005 - Clinical course of patients with chronic hepatitis B with viral breakthrough during long-term lamivudine treatment.
Tatsuya Ide; Ryukichi Kumashiro; Reiichiro Kuwahara; Hiroyuki Koga; Yuriko Koga; Teruko Hino; Kazuo Tanaka; Akiko Hisamochi; Kei Ogata; Michio Sata
Journal of gastroenterology, Jun. 2005 - 久留米大学第 2 内科および関連施設における C 型慢性肝炎に対するコンセンサスインターフェロンの治療成績
井出達也、安倍弘彦、石井邦英、吉田 博、草場信秀、村島史朗、白地美紀、久富斉子、長田英輔、森田恭代、松隈則人、都田憲司、酒井輝文、権藤和久
医学と薬学, Jun. 2005 - Exacerbation of oral erosive lichen planus by combination of interferon and ribavirin therapy for chronic hepatitis C
Nagao Y, Kawaguchi T, Ide T, Kumashiro R, Sata M
Int J Mol Med, Feb. 2005 - Risk factors for development of hepatocellular carcinoma in patients with chronic hepatitis C after sustained response to interferon
Ikeda M, Fujiyama S, Tanaka M, Sata M, Ide T, Yatsuhashi H, Watanabe H
J Gastroenterol, Feb. 2005 - Quantitative studies on the impaired filterability of erythrocytes from patients with liver cirrhosis
Seki R, Okamura T, Maruyama T, Tanaka K, Ide T, Kage M, Sata M, Uyesaka N
日本バイオレオロジー学会誌, 2005 - Hepatitis C virus down-regulates insulin receptor substrates 1 and 2 through up-regulation of suppressor of cytokine signaling 3.
Takumi Kawaguchi; Takafumi Yoshida; Masaru Harada; Takao Hisamoto; Yumiko Nagao; Tatsuya Ide; Eitaro Taniguchi; Hiroto Kumemura; Shinichiro Hanada; Michiko Maeyama; Shinji Baba; Hironori Koga; Ryukichi Kumashiro; Takato Ueno; Hisanobu Ogata; Akihiko Yoshimura; Michio Sata
The American journal of pathology, Nov. 2004 - [Routes of transmission of hepatitis C virus in hyperendemic areas, and molecular epidemiologic study of hepatitis C virus infection].
Kazuo Tanaka; Tatsuya Ide; Michio Sata
Nihon rinsho. Japanese journal of clinical medicine, Jul. 2004 - Adefovir dipivoxil as a treatment for hepatic failure caused by lamivudine-resistant HBV strains.
Reiichiro Kuwahara; Ryukichi Kumashiro; Hiroto Inoue; Ryo Tanabe; Eisuke Tanaka; Teruko Hino; Tatsuya Ide; Yuriko Koga; Michio Sata
Digestive diseases and sciences, Feb. 2004 - Prognostic indicators of breakthrough hepatitis during lamivudine monotherapy for chronic hepatitis B virus infection
Tanaka Y, Yeo AE, Orito E, Ito K, Hirashima N, Ide T, Sata M, Mizokami M
J Gastroenterol, 2004 - Predicting relapse after cessation of lamivudine monotherapy for chronic hepatits B virus infection
Ito K, Tanaka Y, Orito E, Hirashima N, Ide T, Hino T, Kumashiro R, Kato A, Nukaya H, Sakakibara K, Mukaide M, Ito H, Sata M, Ueda R, Mizokami M
Clin Infect Dis, 2004 - Genetic heterogeneity of the precore and the core promoter region of genotype C hepatitis B virus during lamivudine therapy.
Reiichiro Kuwahara; Ryukichi Kumashiro; Shiro Murashima; Kei Ogata; Kazuo Tanaka; Akiko Hisamochi; Teruko Hino; Tatsuya Ide; Eisuke Tanaka; Yuriko Koga; Michio Sata
Journal of medical virology, Jan. 2004 - A real-time quantitative polymerase chain reaction method for hepatitis B virus in patients with chronic hepatitis B treated with lamivudine.
Tatsuya Ide; Ryukichi Kumashiro; Yuriko Koga; Eisuke Tanaka; Teruko Hino; Akiko Hisamochi; Shiro Murashima; Kei Ogata; Kazuo Tanaka; Reiichiro Kuwahara; Michio Sata
The American journal of gastroenterology, Sep. 2003 - Severe alcoholic hepatitis successfully treated by leukocytapheresis: a case report.
Yoshiyasu Tsuji; Ryukichi Kumashiro; Kunihide Ishii; Teruko Arinaga; Yoshihiro Sakamoto; Ryo Tanabe; Kei Ogata; Yuriko Koga; Tatsuya Ide; Naofumi Ono; Eisuke Tanaka; Hirohiko Abe; Michio Sata
Alcoholism, clinical and experimental research, Aug. 2003 - Association of troglitazone-induced liver injury with mutation of the cytochrome P450 2C19 gene.
Ryukichi Kumashiro; Takahiro Kubota; Yuriko Koga; Masatoshi Tanaka; Chizuko Inada; Nobuhide Kusaba; Hiroshi Yoshida; Akiko Hisamochi; Tatsuya Ide; Yuko Tomita; Naoko Masumoto; Kyuichi Tanikawa; Tatsuji Iga; Michio Sata
Hepatology research : the official journal of the Japan Society of Hepatology, Aug. 2003 - Predictive factors for remission and death in 73 patients with autoimmune hepatitis in Japan.
Teruko Hino; Ryukichi Kumashiro; Tatsuya Ide; Yuriko Koga; Kunihide Ishii; Eisuke Tanaka; Yasuyo Morita; Akiko Hisamochi; Shiro Murashima; Kazuo Tanaka; Kei Ogata; Reiichiro Kuwahara; Michio Sata
International journal of molecular medicine, Jun. 2003 - A pilot study of eicosapentaenoic acid therapy for ribavirin-related anemia in patients with chronic hepatitis C.
Tatsuya Ide; Takashi Okamura; Ryukichi Kumashiro; Yuriko Koga; Teruko Hino; Akiko Hisamochi; Kei Ogata; Kazuo Tanaka; Reiichiro Kuwahara; Ritsuko Seki; Michio Sata
International journal of molecular medicine, Jun. 2003 - Incidence of Sjögren's syndrome in Japanese patients with hepatitis C virus infection.
Yumiko Nagao; Shinichiro Hanada; Shyoichiro Shishido; Tatsuya Ide; Ryukichi Kumashiro; Takato Ueno; Michio Sata
Journal of gastroenterology and hepatology, Mar. 2003 - A case of drug induced liver injury related pioglitazone
HISAMOCHI Akiko; KUMASHIRO Ryukichi; KOGA Yuriko; TANAKA Eisuke; IDE Tatsuya; HINO Teruko; MURASHIMA Shiro; OGATA Kei; KUWAHARA Reiichiro; KOGA Hironori; SHISHIDO Shoichiro; UENO Takato; SATA Michio; EGUCHI Takahisa
Nippon Shokakibyo Gakkai Zasshi, Mar. 2003 - Subclones of drug-resistant hepatitis B virus mutants and the outcome of breakthrough hepatitis in patients treated with lamivudine.
Ryukichi Kumashiro; Reiichiro Kuwahara; Tatsuya Ide; Yuriko Koga; Teruko Arinaga; Akiko Hisamochi; Kei Ogata; Kazuo Tanaka; Michio Sata
Intervirology, 2003 - Short term and two-step interferon therapy for chronic hepatitis C patients with low HCV RNA levels.
Tatsuya Ide; Ryukichi Kumashiro; Teruko Hino; Shiro Murashima; Kei Ogata; Yuriko Koga; Michio Sata
Hepatology research : the official journal of the Japan Society of Hepatology, Feb. 2002 - Interferon-gamma brings additive anti-viral environment when combined with interferon-alpha in patients with chronic hepatitis C.
Ryukichi Kumashiro; Tatsuya Ide; Masaru Sasaki; Shiro Murashima; Hiroshi Suzuki; Teruko Hino; Yasuyo Morita; Ichiro Miyajima; Kei Ogata; Eisuke Tanaka; Hiroshi Yoshida; Kyuichi Tanikawa; Michio Sata
Hepatology research : the official journal of the Japan Society of Hepatology, Jan. 2002 - C 型慢性肝炎に対するγIFNα-2a(ロフェロンィ A)治療と Amplocor-HCV Monitor を用いたウイルス量と genotype の同時測定法による効果予測の検討.
井出達也、神代龍吉、山本雄正、渡慶次千、野口和典、長田英輔、平木幹久、村岡晴雄、角野通弘、青木俊親、中野 均、冨士田朋子、佐田通夫.
消化器科, 2002 - Transcription-mediated amplification is more useful in the follow-up of patients with chronic hepatitis B treated with lamivudine
T Ide, R Kumashiro, T Hino, S Murashima, K Ogata, Y Koga, M Sata
Hepatol Res, 2001 - Two-year follow-up study after treatment with lamivudine for chronic hepatitis B: seven cases reported
T Ide, R Kumashiro, H Suzuki, K Tanikawa, M Sata
Hepatol Res, 2000 - Second generation amplicor-HCV monitor assay : clinical features and predictors of the response to interferon
T Ide, R Kumashiro, N Toyoda, K Matsuyama, T Miura, M Sata
Hepatol Res, 2000 - Increased serum IgM class anti-lipid A antibody and therapeutic effect of ursodeoxycholic acid in primary biliary cirrhosis
T Ide, M Sata, H Nakano, H Suzuki, K Tanikawa
Hepato-Gastroenterol, 1997 - Characteristics of complete responders to interferon among patients with chronic hepatitis C with high serum levels of RNA
T Ide, M Sata, H Suzuki, Y Uchimura, M Shirachi, N Adachi, K Tanikawa
Hepatol Res, 1997 - Evaluation of Interferon Treatment in Cirrhotic Patients with Hepatitis C
IDE Tatsuya; SATA Michio; SUZUKI Hiroshi; MURASHIMA Shiroh; MIYAJIMA Ichiroh; SHIRACHI Miki; TANIKAWA Kyuichi
Kansenshogaku Zasshi, 1996 - Clinical evaluation of 4 cases of acute viral hepatitis complicated by pure red cell aplasia
T Ide,M Sata, R Nouno, F Yamashita, H Nakano and K Tanikawa
Am J Gastroenterol, 1994
- Current Status of Hepatitis Medical Care Coordinators in Regional Core Centers for Liver Disease Management in Japan: Results of the Third Survey
Setoyama Hiroko; Enomoto Masaru; Sato Mitsuaki; Sasaki Ryo; Isoda Hiroshi; Tokumoto Yoshio; Ikegami Tadashi; Ohara Masatsugu; Inoue Takako; Ide Tatsuya; Uchida Yoshihito; Kagawa Tatehiro; Tatsuki Sachiko; Sakai Norihiro; Nagahara Takakazu; Toshima Hirotaka; Inoue Jun; Shimakami Tetsuro; Iino Chikara; Hashimoto Masami; Kawata Kazuhito; Suetsugu Astushi; Sawada Koji; Asai Akira; Nanba Shihoko; Endo Mizuki; Yoneda Masato; Korenaga Masaaki
Kanzo, 01 Feb. 2025 - Survey on measures for hepatitis B and C in liver specialty hospitals other than regional core centers
Inoue Taisuke; Ide Tatsuya; Uchida Yoshihito; Ogawa Koji; Inoue Takako; Suetsugu Atsushi; Ikegami Tadashi; Setoyama Hiroko; Inoue Jun; Kakizaki Satoru; Enomoto Masaru; Tatsuki Sachiko; Endo Mizuki; Nagata Kenji; Korenaga Masaaki
Kanzo, 01 Dec. 2023 - 久留米大学医療センターにおける新型コロナウイルス感染症への取り組み—Efforts to deal with coronavirus disease-2019 at Kurume University Medical Center—特集 COVID-19との闘い
江﨑 祐子; 大津 寧; 井出 達也; 惠紙 英昭; 大川 孝浩
久留米医学会雑誌, Dec. 2023 - Present status of hepatitis medical care coordinators in regional core centers for liver disease management in Japan (second report)
Isoda Hiroshi; Enomoto Masaru; Takahashi Hirokazu; Oono Takashi; Inoue Taisuke; Ikegami Tadashi; Ide Tatsuya; Tokumoto Yoshio; Ogawa Koji; Setoyama Hiroko; Uchida Yoshihito; Hashimoto Masami; Hirota Kenichi; Kakizaki Satoru; Tatsuki Sachiko; Inoue Takako; Endo Mizuki; Shimakami Tetsuro; Arao Yoshihisa; Inoue Jun; Suetsugu Atsushi; Nagata Kenji; Korenaga Masaaki
Kanzo, 01 Oct. 2023 - Present status of hepatitis medical care coordinators in regional core centers in Japan
Enomoto Masaru; Hidaka Isao; Inoue Taisuke; Isoda Hiroshi; Ide Tatsuya; Arao Yoshihisa; Uchida Yoshihito; Inoue Takako; Ikegami Tadashi; Kakizaki Satoru; Setoyama Hiroko; Shimakami Tetsuro; Ogawa Koji; Suetsugu Atsushi; Inoue Jun; Endo Mizuki; Nagata Kenji; Korenaga Masaaki
Kanzo, 01 Feb. 2021 - C型肝炎撲滅へ向けて-最新治療と残された患者へのアプローチ-
井出達也
田川医報, 2019 - ウイルス検査と健康診断が「沈黙の臓器」を救う 肝臓の病気
井出達也
2018福岡の頼れるお医者さん, Nov. 2017 - A case of chronic hepatitis B detectable a entecavir resistance mutation (rtA186T)
Amano Keisuke; Tanaka Yasuhito; Hayashi Sanae; Kuwahara Reiichiro; Ogata Kei; Miyajima Ichiro; Arinaga Teruko; Ide Tatsuya; Torimura Takuji
Kanzo, 2015 - 当院および関連病院におけるシメプレビル治療について
井出達也
HCV Infection Forum in Fukuoka, Jul. 2014 - C型慢性肝炎治療の新展開
井出達也
久留米醫學會雜誌, May 2014 - C型肝炎治療困難例への対策:IFN少量長期療法の有用性
井出達也、宮島一郎
消化器内科, Apr. 2014 - 高齢C型肝炎患者の肝発癌年齢の予測
井出達也
第9回九州C型肝炎研究会(KCK), Feb. 2013 - 【抗菌薬と抗ウイルス薬-正しい使い方】抗ウイルス薬治療の実際 HBV
井出達也、宮島一郎、佐田通夫
臨牀と研究, Oct. 2012 - 新時代のウイルス性肝炎学 - 基礎・臨床研究の進歩 Ⅱ. C型肝炎 C型慢性肝炎に対する治療学の進歩 C型慢性肝炎に対するインターフェロン療法 - PEG-IFN・リバビリン併用療法を中心に - 二重濾過血漿交換療法(DFPP)を用いたウイルス除去療法
井出達也
日本臨牀, May 2011 - Novel therapeutic strategy for hepatitis C treatment: Double filtration plasmapheresis and interferon/ribavirin combination therapy
Tatsuya Ide
The 6th International Symposium on Liver Failure and Artificial Liver 2011, Mar. 2011 - C型慢性肝炎におけるインターフェロン治療 - 治療の工夫とウイルス側要因 -
井出達也
第22回肝臓フォーラム(西部), Feb. 2010 - The case of an elderly male patient with autoimmune hepatitis complicated by various immunological abnormalities
Kunitake Yasufumi; Arinaga Teruko; Ogata Kei; Ide Tatsuya; Miyajima Ichiro; Kakiuti Seiya; Kuhara Kouichiro; Kuwahara Reiichiro; Koga Yuriko; Torimura Takuji; Kumashiro Ryukichi; Sata Michio
Kanzo, 2010 - Apheresis for liver failure & viral hepatitis
Tatsuya Ide
Renal Diseases and BioTechnology for Blood Purification 2009, Dec. 2009 - 9.IFNβ1日2回投与と二重濾過血漿交換療法(DFPP)を併用したC型慢性肝炎の1例(一般演題,日本アフェレシス学会第15回九州地方会抄録)
井出,達也; 佐田,通夫; 西田,秀美; 田中,英晴; 上田,誠二; 奥田,誠也; 緒方,梢
日本アフェレシス学会雑誌, 31 Oct. 2009 - インターフェロン治療とうつ病
井出達也、久原孝一郎、佐田通夫
Progress in Medicine, Oct. 2009 - 特集:身体疾患とうつ病 6.各科臨床におけるうつ病診療の実際 4)インターフェロン治療とうつ病
井出達也、久原孝一郎、佐田通夫
Progress in Medicine, Oct. 2009 - Novel therapeutic strategy for Hepatitis C treatment - Double Filtration Plasmapheresis and Interferon/Ribavirin combination Therapy -
Tatsuya Ide
World Summit of antivirals 2009, Jul. 2009 - SF-080-2 血小板減少を伴うC型肝硬変に対するIFN療法 : 脾摘の功罪(脾臓・門脈圧亢進症,サージカルフォーラム,第109回日本外科学会定期学術集会)
緒方 俊郎; 奥田 康司; 嬉野 光俊; 吉田 純; 安永 昌史; 佐藤 英博; 井出 達也; 佐田 通夫; 木下 壽文; 青柳 成明
日本外科学会雑誌, 25 Feb. 2009 - A case of overwhelming postsplenectomy infection (OPSI) with chronic hepatitis type C during peginterferon/ribavirin combination therapy
OKAMURA Shusuke; SAKAI Terufumi; YOSHIKAI Hiroshi; SUMIE Hiroaki; NARITA Kozaburou; KARASHIMA Taku; MAEYAMA Yasuhiko; HIGAKI Koichi; IDE Tatsuya; SATA Michio
Nippon Shokakibyo Gakkai Zasshi, 2009 - C型慢性肝炎のPEG IFN・Rib療法におけるDFPP併用療法
井出達也、西田秀美
日本医事新報, Dec. 2008 - 高齢者のC型慢性肝疾患の治療
井出達也、宮島一郎、佐田通夫
肝胆膵, Nov. 2008 - (2)インターフェロン以外のB型慢性肝炎治療はどうすべきか
井出達也、佐田通夫
肝炎のインターフェロン治療 up to date 2009, Sep. 2008 - C型肝炎-最新治療の進めかた- IFN治療困難症例とその対処法-副作用、高齢者、血球減少を乗り越えるには
井出達也、佐田通夫
Medical Practice, Jul. 2008 - 実地診療における B 型肝炎の治療の実際 核酸アナログをどう使いこなすか? - 2007 最新情報 -
神代龍吉、井出達也、久持顕子、佐田通夫
Medical Practice, Apr. 2007 - ALT 低値持続 B 型肝硬変症の抗ウイルス療法の適応とは?
久持顕子、井出達也、佐田通夫
Medical Practice, Apr. 2007 - インターフェロン以外の B 型慢性肝炎治療はどうすべきか
井出達也、佐田通夫
臨床消化器内科, Mar. 2007 - C 型代償性肝硬変に対するインターフェロンβ治療への期待 - 肝癌撲滅のために -
佐田通夫、八橋 弘、清家正隆、井出達也、矢野博久
Medical Tribune 特別企画, Nov. 2006 - B 型慢性肝炎に対する核酸アナログ製剤の投与
井出達也
日本医事新報, Nov. 2006 - 11.C型慢性肝炎における二重濾過血漿交換(DFPP)によるウイルス減量導入療法の試み(一般演題,日本アフェレシス学会第12回九州地方会抄録)
井出,達也; 佐田,通夫; 西田,秀美; 矢野,淳子; 豊永,まき; 宮崎,洋; 玉置,清志; 奥田,誠也
日本アフェレシス学会雑誌, 31 Oct. 2006 - 抗 HBV 薬
井出達也、佐田通夫
臨床と研究, Sep. 2006 - C 型急性肝炎・全国調査の概要 - 厚生労働省科学研究班 -
緒方 啓、井出達也、有永照子、久持顕子、久原孝一郎、古賀郁利子、神代龍吉、佐田通夫
臨床と研究, Aug. 2006 - 高齢者 C 型慢性肝炎に対する IFN / Ribavirin 併用療法の問題点とその対策
井出達也
消化器科, May 2006 - B 型慢性肝炎
井出達也、佐田通夫
臨床と研究, Feb. 2006 - Impaired filterability of erythrocytes from patients with chronic hepatitis under combined treatment with interferon and ribavirin: Rheologic effects of eicosapentaenoic acid
Seki Ritsuko; Okamura Takashi; Ide Tatsuya; Kamishiro Ryukichi; Sata Michio; Uyesaka Nobuhiro; Maruyama Toru
Proceedings of Annual Meeting of the Physiological Society of Japan, 2006 - I 型治療法 : 私の工夫
井出達也、佐田通夫、由谷 茂、伊東恭悟
肝胆膵, Jan. 2006 - 2. B 型肝炎における肝発癌予防
福嶋伸良、黒松亮子、井出達也、鳥村拓司、神代龍吉、佐田通夫
臨床消化器内科, 2006 - インターフェロン + リバビリン併用療法時の貧血に対する EPA の治療効果
井出達也
久留米内科医会, 2006 - ラミブジン/アデフォビル治療の効果と耐性株出現状況
井出達也、佐田通夫
Bio Clinica, 2006 - 11. C型慢性肝炎における二重濾過血漿交換(DFPP)によるウイルス減量導入療法の試み(日本アフェレシス学会第11回九州地方会抄録)
井出,達也; 佐田,通夫; 西田,秀美; 玉置,清志; 奥田,誠也
日本アフェレシス学会雑誌, 31 Oct. 2005 - Management of chronic hepatitis C
Tatsuya Ide
Seminar on Infectious Hepatitis, Its Epidemiology, Prevention and Treatment, Aug. 2005 - Needlestic accident and hepatitis virus contaimination
Tatsusya Ide
Seminar on Infectious Hepatitis, Its Epidemiology, Prevention and Treatment, Aug. 2005 - ウイルスの遺伝子型によって治療方針はどう変わるか
井出達也、神代龍吉
消化器の臨床, 2005 - C 型慢性肝炎の IFN 初回治療
井出達也、佐田通夫
肝胆膵, Dec. 2004 - 11. 重症型アルコール性肝炎に対する白血球除去カラムの使用経験(日本アフェレシス学会第10回九州地方会抄録)
古賀,郁利子; 桑原,礼一郎; 緒方,啓; 久持,顕子; 田中,一雄; 有永,照子; 井出,達也; 西田,秀美; 神代,龍吉; 佐田,通夫
日本アフェレシス学会雑誌, 31 Oct. 2004 - Breakthrough Hepatitis 対策
桑原礼一郎、井出達也、神代龍吉、佐田通夫
肝胆膵, Oct. 2004 - C 型急性肝炎の治療
井出達也、緒方 啓、佐田通夫
臨床医, Aug. 2004 - 分子疫学的手法による HCV 高感染地区での感染経路の検討
田中一雄、井出達也、佐田通夫
日本臨床 ウイルス性肝炎(上)-基礎・臨床研究の進歩-, Jul. 2004 - ステロイドパルス療法、サイクロスポリン (CyA) とラミブジン (LAM) 投与により改善した B 型急性肝不全の 2 症例
桑原礼一郎、久持顕子、緒方 啓、田中一雄、有永照子、井出達也、古賀郁利子、神代龍吉、佐田通夫
臨床と研究, 2004 - A diet pills-induced acute hepatitis
KUMASHIRO Ryukichi; HINO Teruko; KOGA Yuriko; HISAMOCHI Akiko; ARIMATSU Hidetoshi; KUWAHARA Reiichiro; KUMEMURA Hiroto; IDE Tatsuya; TANAKA Eisuke; SATA Michio
Kanzo, 2003 - C 型急性肝炎の疫学的変遷
井出達也、緒方 啓、佐田通夫
肝胆膵, 2003 - Long-term progress of patients with chronic hepatitis B after administration of Lamivudine.
IDE Tatsuya; KUMASHIRO Ryukichi; YANO Michitami; KOGA Mitsuaki; ISHIBASHI Hiromi; HAYASHIDA Kazuhiro; KATO Arifumi; NAKAO Kazuhiko; YAMAMOTO Kyosuke; MIZUTA Toshihiko; TUBOUCHI Hirohito; HAYASHI Katsuhiro; FURUKAWA Tetsuya; FUJIYAMA Shigetoshi; CHIKAZAWA Hideto; SATA Michio
Kanzo, 2002 - 慢性肝炎
井出達也、佐田通夫
臨床医, 2002 - 抗ウイルス剤の使い方 - HBV と HCV -
井出達也、佐田通夫
臨床と研究, 2002 - 高感染率集団に対する措置
井出達也、佐田通夫
綜合臨床, 2002 - C 型急性肝炎に対するインターフェロン治療.
井出達也、村島史朗、佐田通夫.
肝胆膵, 2002 - Efficacy of surveillance for early detection of hepatocellular carcinoma among patients with HBsAg positive chronic liver disease.
KUROMATSU Ryoko; TANAKA Masatoshi; SHIMAUCHI Yoshihiro; OGATA Riko; IDE Tatsuya; KUMASHIRO Ryukichi; MAJIMA Yasuo; SATA Michio
Kanzo, 2001 - B 型慢性肝炎に対するラミブジン療法
井出達也、佐田通夫
Medical Practice, 2001 - A 型肝炎
井出達也、佐田通夫
化学療法の領域, 2000 - 急性B型肝炎の予後予測
神代 龍吉; 古賀 郁利子; 石井 邦英; 草場 信秀; 村島 史郎; 秋吉 冬彦; 内村 恭代; 田中 公美; 佐々木 優; 宮島 一郎; 日野 照子; 野口 誠司; 井出 達也; 向坂 彰太郎; 佐田 通夫
肝臓, 25 Mar. 1999 - 第24回日本急性肝不全研究会
安藤 量基; 木村 公則; 大西 弘生; 森脇 久隆; 冨田 栄一; 石川 哲也; 各務 伸一; 池田 弘; 仁科 恭一郎; 清野 哲司; 島村 淳之輔; 関山 和彦; 与芝 真; 神代 龍吉; 古賀 郁利子; 石井 邦英; 草場 信秀; 村島 史郎; 秋吉 冬彦; 内村 恭代; 田中 公美; 佐々木 優; 宮島 一郎; 日野 照子; 野口 誠司; 井出 達也; 向坂 彰太郎; 佐田 通夫; 北村 伸哉; 平澤 博之; 菅井 桂雄; 織田 成人; 志賀 英敏; 中西 加寿也; 貞廣 智仁; 藤原 慶一; 横須 賀収; 税所 宏光; 遠藤 龍人; 滝川 康裕; 鈴木 一幸; 坂下 佳子; 岩井 正勝; 佐藤 俊一; 小俣 政男; 矢田 豊; 樋口 清博; 渡辺 明治; 増原 昌明; 鈴木 千衣子; 弘中 孝治; 内田 耕一; 久保 善嗣; 萱野 幸三; 坂井 田功; 沖田 極; 村上 不二夫; 福本 陽平
肝臓, 1999 - 第1回日本肝臓学会大会記録
藤井 公生; 小松 眞史; 堀池 典生; 藤沢 友樹; 西田 勉; 宮本 岳; 春名 能通; 佐藤 智信; 神田 勤; 下村 宏之; 三宅 正展; 石川 晶久; 神坂 和明; 田中 基彦; 藤山 重俊; 今井 康陽; 河田 純男; 藤沢 知雄; 乾 あやの; 植村 正人; 福井 博; 海老沼 浩利; 斎藤 英胤; 室久 俊光; 菅谷 仁; 岸本 幸広; 周防 武昭; 今関 文夫; 横須 賀収; 井出 達也; 佐田 通夫; 土橋 健; 渋谷 明隆; 佐藤 明; 鈴木 博; 武田 康男; 市田 隆文; 小方 則夫; 朝倉 均; 田中 直英; 森山 光彦; 荒川 泰行
肝臓, 1998 - Sequential Interferon-α and β Treatment in Patients with Chronic Hepatitis C
MIYAJIMA Ichiro; SATA Michio; UCHIMURA Yasuyo; IDE Tatsuya; SUZUKI Hiroshi; TANIKAWA Kyuichi
Kansenshogaku Zasshi, 1996 - Urinary Bladder Carcinoma was induced in a Patient treated with Cyclophosphamide for Malignant Lymphoma.
YOSHIMOTO Kohji; HISAMOCHI Akiko; OGATA Hideaki; IDE Tatsuya; NOHNO Ryuuichi; FUJITA Mitsutake; KUBOYAMA Shinnichi; SASAKI Ei; TOYONAGA Atsushi; TANIKAWA Kyuuichi; SHIMADA Akihiko; YAMASHITA Takuro; NODA Shinshi; NAKASHIMA Yutaka
Rinsho Ketsueki, 1994 - A Study of Erythrocyte C3b Receptors (E-CR1) in Patients with Acute Viral Hepatitis
MURAOKA Haruo; SATA Michio; NAKANO Hitoshi; HINO Teruko; IDE Tatsuya; TANIKAWA Kyuichi
Kansenshogaku Zasshi, 1993 - Effectiveness of 6-Month Intermittent Administration of Natural Human Interferon-α against Non-A Non-B Chronic Hepatitis
SATA Michio; ATONO Yoshihiro; NAKANO Hitoshi; MORITA Yasuyo; HINO Teruko; IDE Tatsuya; NOGUCHI Seiji; TOKESHI Shigeru; YANO Yoichi; ONO Katsuyuki; MURAOKA Haruo; HINO Kazuhiko; TANIKAWA Kyuichi
Kansenshogaku Zasshi, 1992 - A Study on Hepatic Dysfunction Associated with Rubella Infection
MURAOKA Haruo; SATA Michio; HINO Teruko; IDE Tatsuya; NOGUCHI Seiji; TOKESHI Shigeru; YANO Yoichi; ONO Katsuyuki; ATONO Yoshihiro; SUZUKI Hiroshi; NAKANO Hitoshi; ABE Hirohiko; TANIKAWA Kyuichi
Kansenshogaku Zasshi, 1991 - A case report of chronic hepatitis B associated with HTLV-I healthy carrier who showed Type I response (Merigan) to adenine arabinoside therapy.
NAKANO Hitoshi; SATA Michio; HINO Kazuhiko; SUZUKI Hiroshi; MURAOKA Haruo; ATONO Yoshihiro; ONO Katsuyuki; IDE Tatsuya; KUMASHIRO Ryukichi; ABE Hirohiko; TANIKAWA Kyuichi
Kanzo, 1990 - Studies on anti-HCV in hepatocellular carcinoma with alcoholic cirrhosis.
ISHII Kunihide; SATA Michio; KUMASHIRO Ryukichi; IDE Tatsuya; NAKANO Hitoshi; TANAKA Shinpei; FURUDERA Shigeki; TANAKA Masatoshi; MAJIMA Yasuo; HIRAI Kenji; ABE Hirohiko; TANIKAWA Kyuichi
Kanzo, 1990
- AnswerのPoint key words 健康キャリア、仕事上の制限
井出達也、佐田通夫、松崎靖司、宜保行雄 編, Contributor
患者さんの質問に答える慢性肝疾患診療改訂2版、南江堂, Apr. 2008 - AnswerのPoint key word ウイルス量
井出達也、佐田通夫、松崎靖司.宜保行雄 編, Contributor
患者さんの質問に答える慢性肝疾患診療改訂2版、南江堂, Apr. 2008 - 最近19年間の薬物性肝障害の実態
久持顕子、日野照子、古賀郁利子、神代龍吉、井出達也、宮島一郎、緒方 啓、久原孝一郎、桑原礼一郎、佐田通夫, Contributor
薬物性肝障害の実態, 2008 - C型慢性肝炎のPEG IFN・Rib療法におけるDFPP併用療法
井出達也、西田秀美, Contributor
日本医事新報, 2008 - 急性肝炎
井出達也、佐田通夫. 和田 攻、大久保昭行、他 編., Contributor
「内科外来診療実践ガイド - 縮刷版 -」文光堂, Apr. 2006 - 急性ウイルス肝炎
井出達也、佐田通夫. 井廻道夫、他 編., Contributor
「肝臓病学」朝倉書店, 2006 - Needlestick Accident and hepatitis virus contamination
Ide T, Contributor
Seminar on infectious hepatitis, its epidemiology, prevention and treatment, 2006 - 急性肝炎
井出達也、佐田通夫. 上西紀夫、菅野健太郎、田中雅夫、滝川 一 編., Contributor
「講義録 消化器学」メジカルビュー社, Apr. 2005 - 急性肝炎の診断と治療(各論): (3)C 型急性肝炎
緒方 啓、井出達也、佐田通夫. 林 紀夫 編., Contributor
「新しい診断と治療の ABC 27/ 消化器3 ウイルス性肝炎」最新医学社, Feb. 2005 - (1) B 型肝炎治療の動向 (ラミブジン, Adefovir, Entecavir)
神代龍吉、井出達也、佐田通夫. 河田純男、白鳥康史 等編, Contributor
「肝疾患 Review 2004」日本メディカルセンター 出版, Jun. 2004 - アンプリコアモニター法による治療戦略
井出達也、佐田通夫. 河田純男、白鳥康史 等編, Contributor
「C 型慢性肝炎治療の新たなストラテジー」先端医学社 出版, Mar. 2004 - Management of Chronic Hepatitis C
Ide T, Contributor
「Textbook of JICA Seminar on infectious hepatitis-its epidemiology and control」, 2004 - Needlestick accident and hepatitis virus contamination.
Ide T, Contributor
「Textbook of JICA Seminar on infectious hepatitis-its epidemiology and control」, 2004 - C 型急性肝炎の感染経路と治療
井出達也、佐田通夫, Contributor
The Proceedings of The 23rd Inuyama Symposium 「B 型・C 型肝炎治療の新たな展開」アークメディア出版, 2002
- Stratified analysis by hepatocarcinogenesis risk factors in SVR patients with DAA treatment for hepatitis C
Tatsuya Ide, Hiroshi Isoda, Masaru Harada
JDDW workshop, Nov. 2021 - Elderly Hepatitis Cpatients Who Achieved Sustained Virological Response by Direct Acting Antivirals do not Havesignificant Benefits for Hepaticellular Carcinoma Compared with The Patients Who did not Achieved Sustained Virological Response
Ide T, Eguchi Y, Harada M, Arinaga-Hino T, Kuwahara R, Kawaguchi T, Amano K, Isoda H, Honma Y and Torimura T
The 70th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD), Nov. 2019 - パネルディスカッション(9) 肝炎ウイルス感染者の効果的な診療体制の確立 当県における肝疾患専門医療機関での院内肝炎ウイルス陽性患者の拾い上げに関する検討
井出達也、天野恵介、鳥村拓司
第105回日本消化器病学会総会, May 2019 - パネルディスカッション(1) VR後C型肝疾患の長期予後:肝発癌,QOL,肝外疾患への影響 C型肝疾患でのDAAs治療SVR例(とくに高齢者,肝硬変)での肝機能改善に関する検討
井出達也、江口有一郎、原田 大
第55回日本肝臓学会総会, May 2019 - メディカルスタッフセッション(2) 肝疾患の医療行政:各都道府県での実態と課題 福岡県における肝炎ウイルス検査陽性者の精密検査受診率の検討
井出達也、天野恵介、鳥村拓司
第55回日本肝臓学会総会, May 2019 - シンポジウム(1)C型肝疾患でのDDAs治療SVR例の発癌寄与因子の検討-新規線維化マーカーの有用性-
井出達也、江口有一郎、原田 大
26th JDDW(第22回肝臓学会大会、第60回日本消化器病学会大会、第16回日本消化器外科学会大会 合同), Nov. 2018 - シンポジウム(2) 肝炎ウイルス制御後発癌の実体と対応策C型肝疾患でのDDA治療SVR例の 発癌についての検討
井出達也、黒松亮子、有永照子、桑原礼一郎、天野惠介、佐野有哉、鳥村拓司
第54回日本肝癌研究会, Jun. 2018 - C 型慢性肝疾患における ELF スコアの有用性―DAA 治療前後の推移と肝癌との関連に関する検ー
井出達也、川口俊弘、鳥村拓司
第54回日本肝臓学会総会, Jun. 2018 - 福岡県医学会受賞者講演:C型慢性肝疾患に対するダクラタスビル/アスナプレビル併用療法-ダイレクトシークエンス法によるHCV薬剤耐性変異の解析と治療効果に関する検討-
井出達也
第10回福岡県医学会総会, Feb. 2018 - パネルディスカッション(1)多施設共同研究におけるC型肝疾患へのDAAs治療の検討
井出達也、江口有一郎、原田 大
肝臓、24th JDDW(第20回日本肝臓学会大会、第58回日本消化器病学会大会 合同), Nov. 2016 - ワークショップ(3)当院におけるC型慢性肝疾患に対するDirect Acting Antivirals(DAAs)療法の検討
井出達也、有永照子、宮島一郎、緒方 啓、桑原礼一郎、天野恵介、鳥村拓司
第107回日本消化器病学会九州支部例会、第101回日本消化器内視鏡学会九州支部例会 合同, Jun. 2016 - C型慢性肝疾患に対するソホスブビル/リバビリン併用療法の治療効果と有害事象に影響する因子の検討
本間雄一、井出達也、原田 大
肝臓、第52回日本肝臓学会総会, May 2016 - ワ-クショップ(9)C型肝疾患での重度の合併症を有する例・高度肝線維化親展例へのDAAs治療の現況
井出達也、江口有一郎、鳥村拓司
肝臓、第52回日本肝臓学会総会, May 2016 - 腎機能低下症例におけるダクラタスビル・アスナプレビル併用療法の意義
岡田倫明、井出達也、江口有一郎
肝臓、第52回日本肝臓学会総会, May 2016 - パネルディスカッション(2)薬剤耐性変異からみたDaclatasuvir/Asunaprevir併用療法の治療効果
井出達也、有永照子、鳥村拓司
日本消化器病学会雑誌、第102回日本消化器病学会総会, Apr. 2016 - Poster Session: DAAs NS3 Inhibitor plus NS5A Inhibitor (3)Predictive markers of viral response to daclatasvir/asunaprevir in HCV genotype 1 patients
Ide T, Arinaga T, Miyajima I, Ogata K, Kuwahara R, Amano K, Okada M, Eguchi Y, Honma Y, Harada M, Torimura T
Hepatology International、25th Conference of the Asian Pacific Association for the Study of the Liver (APASL), Feb. 2016 - C型肝炎治療著効後の肝発癌に関する検討
井出達也、有永照子、鳥村拓司、宮島一郎、緒方 啓、桑原礼一郎、天野恵介
肝臓、第41回日本肝臓学会西部会, Dec. 2015 - C型慢性肝疾患に対するDaclatasvir/Asunaprevir併用療法の治療効果:多施設共同研究での検討
井出達也、原田 大、本間雄一、江口有一郎、大枝 敏、鳥村拓司
肝臓、23rd JDDW(第19回日本肝臓学会大会), Oct. 2015 - ワークショップ(2)当院におけるC型慢性肝疾患に対するDaclatasvir/Asunaprevir療法の検討
井出達也、有永照子、宮島一郎、緒方 啓、桑原礼一郎、天野恵介、黒松亮子、住江修治、新関 敬、鳥村拓司
プログラム・抄録集 : 第105回日本消化器病学会九州支部例会、第99回日本消化器内視鏡学会九州支部例会 合同, Jun. 2015 - C型慢性肝疾患におけるIFN 治療難治例(G1の高齢者,線維化進展例)の検討
井出達也、有永照子、宮島一郎、緒方 啓、桑原礼一郎、天野恵介、鳥村拓司、野口和典、森田恭代、石井邦英、坂田雅浩、白地美紀、福嶋博文
肝臓、第51回日本肝臓学会総会, May 2015 - パネルディスカッション(8)C型肝炎治療著効後の肝発癌に関する治療前,治療後の経過の検討
井出達也、有永照子、鳥村拓司
日本消化器病学会雑誌、第101回日本消化器病学会総会, Apr. 2015 - Research Forum(3)TVR3剤併用療法の早期HCV動態から見た治療効果予測
島田紀朋、高口浩一、井出達也、加藤慶三、坪田昭人、豊田秀徳、熊田 卓、佐田通夫
日本消化器病学会雑誌、第100回日本消化器病学会総会, Apr. 2014 - C型慢性肝疾患におけるインターフェロン治療後biochemical responderの長期経過の検討
井出達也、有永照子、宮島一郎、緒方 啓、桑原礼一郎、天野恵介、佐田通夫
肝臓、第40回日本肝臓学会西部会, Dec. 2013 - IL28b gene and very early viral kinetics (Week-1) predict sustained virological response to triple therapy in chronic hepatitis C patients with genotype 1b and high viral load
Ide T, Takaguchi K, Toyoda H, Kumada T, Shimada N, Kato K, Tsubota A, Izumi N, Sata M
Hepatology、The 64th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD), Nov. 2013 - ペグインターフェロンリバビリン併用療法を先行したテラプレビル治療の検討
井出達也、有永照子、佐田通夫
肝臓、第49回日本肝臓学会総会, Jun. 2013 - ワ-クショップ(1)C型肝炎治療困難例への対策 : PEG-IFN少量長期投与療法の有効性の検討
井出達也、宮島一郎、佐田通夫
日本消化器病学会雑誌、第99回日本消化器病学会総会, Mar. 2013 - ワークショップ(2) 高齢C型慢性肝疾患患者における年令別検査値からみた肝発癌の検討
井出達也、有永照子、佐田通夫
肝臓、20th JDDW(第16回日本肝臓学会大会、第54回日本消化器病学会大会、第50回日本消化器がん検診学会大会 合同), Oct. 2012 - IL28B SNPメジャータイプにおけるPEG IFN/RBV治療の検討
井出達也、泉 並木、熊田 卓、島田紀朋、高口浩一、豊田秀徳、佐田通夫
肝臓、第48回日本肝臓学会総会, Jun. 2012 - シンポジウム(5)B型慢性肝炎の治療
井出達也
日本化学療法学会雑誌、第60回日本化学療法学会学術集会, Apr. 2012 - C型慢性肝炎のインターフェロン治療難治例と予測される症例へのIFNβ1日2回投与と 二重慮過血漿交換療法
井出達也、有永照子、宮島一郎、緒方 啓、桑原礼一郎、佐田通夫
第97回日本消化器病学会九州支部例会、第91回日本消化器内視鏡学会九州支部例会 合同, Jun. 2011 - C型慢性肝炎難治例に対するIFNβ1日2回投与および二重濾過血漿交換療法の応用とHCVアミノ酸変異
井出達也、有永照子、宮島一郎、緒方 啓、桑原礼一郎、佐田通夫
肝臓、18th JDDW(第14回日本肝臓学会大会), Oct. 2010 - 高齢女性におけるC型慢性肝疾患のインターフェロン治療効果の検討
井出達也、有永照子、宮島一郎、緒方 啓、久原孝一郎、桑原礼一郎、佐田通夫
肝臓、第46回日本肝臓学会総会, May 2010 - 体重別にみたPEG IFNリバビリン併用療法の治療効果
井出達也、有永照子、佐田通夫
肝臓、第38回日本肝臓学会西部会, Dec. 2009 - ワ-クショップ(2)ウイルス性肝炎に対する最新の治療 : C型慢性肝炎難治例に対する治療の工夫 -IFNβ1日2回投与および二重濾過血漿交換療法の応用-
井出達也、有永照子、宮島一郎、緒方 啓、久原孝一郎、桑原礼一郎、佐田通夫
第94回日本消化器病学会九州支部例会、第88回日本消化器内視鏡学会九州支部例会 合同, Nov. 2009 - 体重別にみたPEG IFNリバビリン併用療法の治療効果
井出達也、佐田通夫
肝臓、17th JDDW(第13回日本肝臓学会大会、第51回日本消化器病学会大会 合同), Oct. 2009 - C型慢性肝炎における二重濾過血漿交換(DFPP)併用療法の治療効果とその工夫
井出達也、佐田通夫
日本アフェレシス学会雑誌、第30回日本アフェレシス学会学術大会, Sep. 2009 - C型慢性肝炎のIFN治療無効例に、二重濾過血漿交換療法(DFPP)とIFNβ1日2回投与を併用した1例
井出達也、有永照子、宮島一郎、緒方 啓、久原孝一郎、桑原礼一郎、西田秀美、奥田誠也、佐田通夫
第93回日本消化器病学会九州支部例会、第87回日本消化器内視鏡学会九州支部例会 合同, Jun. 2009 - 55?65Kgでの体重別にみたPEG IFNリバビリン併用療法の治療効果
井出達也、有永照子、宮島一郎、緒方 啓、久原孝一郎、桑原礼一郎、佐田通夫
肝臓、第45回日本肝臓学会総会, Jun. 2009 - Novel therapeutic strategy for chronic hepatitis C - Double filtration plasmapheresis and (PEG) interferon/ribavirin combination therapy
Tatsuya Ide
12th World Apheresis Association and 7th International Society for Apheresis Congress, Mar. 2009 - A PEG-interferon/ribavirin combination treatment for genotype 1b with high viral load - The characteristics of the non sustained viral response patients whose HCV RNA became negative at 12-16 weeks
Tatsuya Ide, Teruko Arinaga, Kei Ogata, Ichiro Miyajima, Kouichiro Kuhara, Reiichiro Kuwahara, Michio Sata
Hepatology International、19th Conference of the Asian Pacific Association for the Study of the Liver (APASL), Feb. 2009 - PEG-Interferon/Ribavirin併用療法の延長投与例におけるSVRに関与する因子の検討
井出達也、有永照子、宮島一郎、緒方 啓、久原孝一郎、桑原礼一郎、佐田通夫
第92回日本消化器病学会九州支部例会、第86回日本消化器内視鏡学会九州支部例会 合同, Nov. 2008 - Genotype 1b、高ウイルス量に対するPEG-Interferon/Ribavirin併用療法- 12?16週RNA陰性化例でのnonSVR例の特徴-
井出達也、有永照子、宮島一郎、緒方 啓、久原孝一郎、桑原礼一郎、佐田通夫
肝臓、16th JDDW(第12回日本肝臓学会大会), Oct. 2008 - Evaluation of long-term entecavir (ETV) treatment in stable chronic hepatitis B patients switched from lamivudine (LVD) therapy
Tatsuya Ide, Michio Sata, Michiko Sindo, Kazuaki Chayama, Joji Toyota, Satoshi Mochida, Eiichi Tomita, Hiroshi Yatsuhashi, Norio Hayashi, Hiroki Ishikawa, Taku Seriu, Masao Omata
Hepatology、The 59th Annual Meeting of the American Association for the Study of Liver Diseases(AASLD), Oct. 2008 - Genotype 1, 高ウイルス量に対するPEG-Interferon/Ribavirin併用療法の延長投与の検討
井出達也、有永照子、宮島一郎、緒方 啓、久原孝一郎、桑原礼一郎、古賀郁利子、佐田通夫
肝臓、第44回日本肝臓学会総会, Jun. 2008 - 超高ウイルス量例へのPEG IFNリバビリン+二重濾過膜血漿交換療法の治療効果
井出達也、佐田通夫、西田秀美、奥田誠也
第53回日本透析医学会学術集会・総会, Jun. 2008 - 当科における血小板数低値例に対するペグインターフェロン・リバビリン併用療法
井出達也、有永照子、宮島一郎、緒方 啓、久原孝一郎、桑原礼一郎、古賀郁利子、神代龍吉、佐田通夫
肝臓、第37回日本肝臓学会西部会, Dec. 2007 - C 型慢性肝炎に対するPEG-Interferon / Ribavirin 併用療法の実態調査 - アンケートによる意識調査および臨床効果の実態調査
井出達也、佐田通夫、坪内博仁
肝臓、15th JDDW (第11回日本肝臓学会大会), Oct. 2007 - PEG-Interferon/Ribavirin 併用療法の延長投与例における SVR に関与する因子の検討
井出達也、有永照子、緒方 啓、宮島一郎、久原孝一郎、桑原礼一郎、神代龍吉、佐田通夫
肝臓、15th JDDW 第11回日本肝臓学会大会, Oct. 2007 - C型慢性肝炎における二重濾過血漿交換(DFPP) によるウイルス減量導入療法
井出達也、藤原研司、西田秀美、奥田誠也、金子周一、各務伸一、持田 智、矢野淳子、柴田 了、楠本拓生、深水圭
第52回日本透析医学会学術集会・総会, Jun. 2007 - HCV RNA 陰性化時期に応じた PEG IFN リバビリン延長投与の検討
井出達也、有永照子、久持顕子、緒方 啓、久原孝一郎、古賀郁利子、神代龍吉、佐田通夫
肝臓、第43回日本肝臓学会総会, May 2007 - Novel therapeutic strategy for chronic hepatitis C : Double filtration plasmapheresis and (PEG) interferon/ribavirin Combination therapy
Tatsuya Ide, Hidemi Nishida, Jyunko Yano, Hideharu Tanaka, Seiya Okuda, Michio Sata
International Congress on ESRD 2006, Nov. 2006 - ペグインターフェロン・リバビリン併用療法における減量中止例の検討
井出達也、有永照子、久持顕子、緒方 啓、久原孝一郎、古賀郁利子、神代龍吉、佐田通夫
第88回日本消化器病学会九州支部例会、第82回日本消化器内視鏡学会九州支部例会 合同, Nov. 2006 - C型慢性肝炎における二重濾過血漿交換(DFPP)によるウイルス減量導入療法 - ウイルス減量導入研究会 -
井出達也、佐田通夫、藤原研司
14th DDW-Japan(第10回日本肝臓学会大会、第48回日本消化器病学会大会 合同), Oct. 2006 - C型慢性肝炎のIFN治療無効例に、二重濾過血漿交換療法(DFPP)とIFNβ1日2回投与を併用した1例
井出達也、有永照子、宮島一郎、緒方 啓、久原孝一郎、桑原礼一郎、西田秀美、奥田誠也、佐田通夫
第93回日本消化器病学会九州支部例会、第87回日本消化器内視鏡学会九州支部例会 合同, Jun. 2006 - C 型慢性肝炎における二重濾過血漿交換(DFPP)によるウイルス減量導入療法
井出達也、西田秀美、緒方 梢、矢野淳子、玉置清志、佐田通夫、奥田誠也
第51回日本透析医学会学術集会・総会, Jun. 2006 - C 型慢性肝炎における二重濾過血漿交換(DFPP)によるウイルス減量導入療法の試み
井出達也、神代龍吉、有永照子、久持顕子、久原孝一郎、古賀郁利子、緒方 啓、佐田通夫、西田秀美
肝臓、第42回日本肝臓学会総会, May 2006 - C 型慢性肝炎における二重濾過血漿交換(DFPP)によるウイルス減量導入療法の試み
井出達也、佐田通夫、西田秀美、矢野淳子、豊永まき、宮崎 洋、玉置清志、奥田誠也
第12回日本アフェレシス学会九州地方会, Apr. 2006 - ラミブジン耐性株に対するアデフォビル単独療法の臨床的検討
井出達也、神代龍吉、佐田通夫
肝臓、第36回日本肝臓学会西部会, Nov. 2005 - 高齢者に対するインターフェロンリバビリン併用療法の問題とその対策
井出達也、神代龍吉、佐田通夫
DDW-Japan(第9回日本肝臓学会大会、第47回日本消化器病学会大会、第43回日本消化器集団検診学会大会 合同), Oct. 2005
- 内科学の授業の「肝硬変」に関して教材を作成した。A4版、3頁
May 2008 - 内科学の授業の「急性肝炎」に関して教材を作成した。A4版、５頁
Oct. 2004 - 肝疾患のテーラメード医療について講義を行った。
- 肝硬変の講義において、まず何の情報も与えずに患者の写真を見せ、観察させどこが異常かなどを考えさせた。 観察力、集中力の訓練になると考えられた。
■ 共同研究実績
- 分岐鎖アミノ酸含有食品(アミノフィール)の開発:生活文化舎との共同研究
- C型肝炎に対するテラプレビル治療の共同研究 論文作成済み
- C型非代償性肝硬変に対する抗ウイルス薬治療の効果に関する検討 論文作成済み
■ 関心を持って取組んでいる活動
